| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.500 | None | 1.000 | 10 | 4 | 2005 | 2018 | ||||||||
|
G protein subunit alpha i2 | 0.636 | 0.577 | 0.89 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
protein kinase cAMP-dependent type I regulatory subunit alpha | 0.401 | 0.846 | 1.00 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
isocitrate dehydrogenase (NADP(+)) 1 | 0.424 | 0.808 | 2.6E-12 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
isocitrate dehydrogenase (NADP(+)) 2 | 0.434 | 0.808 | 0.88 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 1999 | 2014 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 1999 | 2008 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2002 | 2019 | ||||||||
|
transcription factor 21 | 0.537 | 0.692 | 0.83 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2017 | ||||||||
|
coronin 7 | 0.628 | 0.692 | 1.8E-25 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2015 | ||||||||
|
insulin like growth factor binding protein 2 | 0.478 | 0.769 | 0.12 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2004 | 2004 | ||||||||
|
inhibin subunit alpha | 0.578 | 0.615 | 6.5E-03 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2019 | ||||||||
|
GATA zinc finger domain containing 2B | 0.593 | 0.654 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
aldo-keto reductase family 1 member B10 | 0.546 | 0.769 | 7.6E-09 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
protein kinase C beta | 0.453 | 0.885 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
cellular communication network factor 3 | 0.554 | 0.615 | 6.6E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
protein kinase C alpha | 0.440 | 0.846 | 0.37 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
chorionic gonadotropin subunit beta 5 | 0.579 | 0.654 | 2.5E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
retinoic acid receptor responder 2 | 0.519 | 0.731 | 2.7E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1998 | 1998 |